XTX Topco Ltd Has $33,000 Position in DarioHealth Corp. (NASDAQ:DRIO)

XTX Topco Ltd increased its holdings in shares of DarioHealth Corp. (NASDAQ:DRIOFree Report) by 81.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 29,455 shares of the company’s stock after purchasing an additional 13,219 shares during the period. XTX Topco Ltd’s holdings in DarioHealth were worth $33,000 at the end of the most recent reporting period.

Separately, DLK Investment Management LLC lifted its holdings in shares of DarioHealth by 71.6% during the third quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock worth $113,000 after buying an additional 41,943 shares during the last quarter. Institutional investors own 33.39% of the company’s stock.

DarioHealth Trading Up 8.1 %

Shares of DarioHealth stock opened at $0.80 on Monday. DarioHealth Corp. has a 1 year low of $0.65 and a 1 year high of $2.60. The company’s fifty day simple moving average is $0.85 and its 200-day simple moving average is $0.98. The company has a market cap of $27.28 million, a price-to-earnings ratio of -0.85 and a beta of 1.47. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35.

DarioHealth Profile

(Free Report)

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Featured Articles

Want to see what other hedge funds are holding DRIO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DarioHealth Corp. (NASDAQ:DRIOFree Report).

Institutional Ownership by Quarter for DarioHealth (NASDAQ:DRIO)

Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.